It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or
consider using other browsers such as Chrome, Firefox or Safari.
At OmniSource®, we're dedicated to making growth hormone (GH) treatment more accessible for your patients. The Omnitrope® Self Pay Program is the most comprehensive among daily somatropins because it includes two formulation options to meet your patients' needs.
To claim this offer for your patients, please fax the patient’s Omnitrope prescription to one of our preferred Specialty Pharmacy partners who will verify eligibility and assign the patient a member ID.
For more information or to see a full list of our Specialty Pharmacy partners, contact us today at 877.456.6794.
1. Data on File. Potential savings based upon 1) average monthly liquid milligram usage by Omnitrope Self Pay patients during 2020, and 2) Omnitrope liquid wholesale acquisition cost as of January 2021. This is not a guarantee of any particular savings or cost reduction, and individual results may vary.
Help your patients make a great start on their growth journey by enrolling them in OmniSource.
The OmniSource team provides personalized support services to help your patients each step of the way.
Savings support for the journey ahead - eligible patients may pay as little as $0 for their Co-Pay.†
Personalized support, each step of the way. Click here to enroll your patient.
Omnitrope® is a recombinant human growth hormone indicated for:
Please see full Prescribing Information for Omnitrope.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch